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Abstract
Background: Mitochondrial 2-oxoglutarate (a-ketoglutarate) dehydrogenase complex (OGDHC), a key regulatory
point of tricarboxylic acid (TCA) cycle, plays vital roles in multiple pathways of energy metabolism and biosynthesis.
The catalytic mechanism and allosteric regulation of this large enzyme complex are not fully understood. Here
computer simulation is used to test possible catalytic mechanisms and mechanisms of allosteric regulation of the
enzyme by nucleotides (ATP, ADP), pH, and metal ion cofactors (Ca
2+ and Mg
2+).
Results: A model was developed based on an ordered ter-ter enzyme kinetic mechanism combined with con-
formational changes that involve rotation of one lipoic acid between three catalytic sites inside the enzyme
complex. The model was parameterized using a large number of kinetic data sets on the activity of OGDHC, and
validated by comparison of model predictions to independent data.
Conclusions: The developed model suggests a hybrid rapid-equilibrium ping-pong random mechanism for the
kinetics of OGDHC, consistent with previously reported mechanisms, and accurately describes the experimentally
observed regulatory effects of cofactors on the OGDHC activity. This analysis provides a single consistent
theoretical explanation for a number of apparently contradictory results on the roles of phosphorylation potential,
NAD (H) oxidation-reduction state ratio, as well as the regulatory effects of metal ions on ODGHC function.
Background
The 2-oxoglutarate (a-ketoglutarate; aKG) dehydrogen-
ase complex (OGDHC, EC 1.2.4.2, EC 2.3.1.61, and EC
1.6.4.3) is a multi-enzyme complex which catalyzes the
chemical reaction:
αKG2- +C o A S H 4− +N A D − +H 2O 
Succinyl - CoA4− +C O 2−
3 +N A D H 2− +H+ (1)
OGDHC is primarily located within the mitochondrial
matrix and is a key regulatory enzyme complex in the
TCA cycle, responsible for oxidative decarboxylation of
2-oxoglutarate, transferring a succinyl group to coen-
zyme A (CoASH
4-) and producing reducing equivalents
(NADH
2-) for the electron transport system. Regulation
of OGDHC not only affects the distribution of 2-oxoglu-
tarate between the TCA cycle and malate-aspartate
shuttle system, but also has effects on the oxidative
deamination of glutamate. OGDHC is a crucial target of
reactive oxygen species (ROS) and also able to generate
ROS, which make it distinctly important for bioener-
getics [1]. The molecular organization of OGDHC is
similar to that of the pyruvate dehydrogenase complex
(PDHC) as it belongs to the same heterogeneous family
of 2-oxo acid dehydrogenase multi-enzyme complexes
[2]. It consists of multiple copies of three enzyme com-
ponents: oxoglutarate dehydrogenase (E1), dihydro-
lipoamide succinyltransferase (E2), and dihydro-lipoa-
mide dehydrogenase (E3). Consecutive actions of these
enzymes catalyze the oxidation of 2-oxoglutarate and
reduction ofNAD
-, which results in the production of
NADH
2- and Succinyl-CoA
4- (Figure 1A). Allosteric
interactions associated with the E1 component are
known to be the predominant target for controlling of
OG-DHC activity [3].
OGDHC was first purified from the pig heart mito-
chondria by Sanadi et al. [4] and subsequently studied
by many researchers to examine its catalytic and regula-
tory properties within permeabilized, un-coupled, and
coupled mitochondria from a variety of mammalian
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Figure 1 Schematic representation of the proposed mechanism of 2-oxoglutarate dehydrogenase complex (OGDHC). (A) It consists of
three component enzymes: oxoglutarate dehydrogenase (E1), dihydro-lipoamide succinyltransferase (E2), and dihydro-lipoamide dehydrogenase
(E3). The schematic representation here does not describe true stoichiometry of the multiple copies of three enzymes in the complex. The
binding domain and lipoyl domain of E2 polypeptide are connected to the complex core with flexible links (dotted lines), are used here to
describe the mechanism in which a single lipoic acid rotates between the three catalytic sites. In the catalytic cycle, the disulfide at the tip of
the lipoyl can be in oxidized, reduced or semi-reduced lipoate forms, the later one is connected with succinyl residue transferred from
oxoglutarate. (B) This schematic illustrates the proposed kinetic schemes along with the mechanism of conformational changes. The forward
reaction is read in the clockwise direction. The complex has three binding sites: one for each composite enzyme. E1 binds to 2-oxoglutarate or
corresponding product CO2 (top), E2 binds to COA or corresponding product Succinyl-CoA (bottom-right), E3 binds to NAD or corresponding
product NADH (bottom-left). It is assumed that, in the process of conformational changes, the rotation of one lipoic acid between three catalytic
sites leads to transfer succinyl from E1 to E2 and proton from E2 to E3.
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Page 2 of 15tissues [5-11]. A catalytic mechanism for the overall
reaction of the enzyme complex was also first proposed
by Sanadi et al. [4] which suggested that the coenzyme,
NAD
-, and 2-oxoglutaric acid participate in the reaction
with the help of the cofactors thiamine pyrophosphate
(TPP), lipoic acid, and FAD
2- [12,13]. Their proposed
mechanism is a Hexa-Uni-Ping-Pong mechanism in Cle-
land’s terminology [14] where it is assumed that the first
product (CO2) is released before the second substrate
(CoASH
4-)b i n d s ,a n dt h es e c o n dp r o d u c t( S u c c i n y l -
CoA
4-) is released before the third substrate (NAD
-)
b i n d st ot h ee n z y m e .S u b s e q u e n t l y ,K o i k eet al.[ 1 5 ]
postulated another mechanism in which, the lipoic acids
transfer intermediates by rotating between the three cat-
alytic sites. Furthermore, experimental results of fluores-
cence resonance energy transfer and dynamic anisotropy
showed that the lipoic acids in the E2 component
undergo motion where they rotate between different
catalytic sites [16-18]. The results of steady-state kinetic
studies done by Hamada et al. [19] and Smith et al. [10]
contradict each other, and not all results are compatible
with the Sanadi mechanism [4]. This issue was
addressed by Mcminn and Ottaway [20] with kinetic
studies based on the Fromm method [21]. Mcminn and
Ottaway [20] explained the observed nonlinearity in the
reciprocal plots of the results and proposed a phenom-
enological mechanism with semi-random characteristic.
A recent study by Aevarsson et al.[ 2 2 ]o nt h ec r y s t a l
structure and architecture of 2-oxo acid dehydrogenase
multi-enzyme complexes, provides interesting insights
into the plausible kinetic mechanism of 2-oxo acid
dehydrogenase family which includes OGDHC.
It has been consistently shown that the activity of
OGDHC is controlled by various factors, including the
variations of the NAD oxidation-reduction state, the
state of phosphorylation of the nucleotide systems, and
the ratio of succinyl-CoA to CoA-SH. Regulation by
reversible phosphorylation has not been demonstrated.
Experiments in isolated mitochondria of heart, liver, and
kidney have shown that the OGDHC is regulated by Ca
2
+ ions with a marked decrease in the apparent Km for 2-
oxoglutarate in the presence of adenine nucleotides and
minimal effect of Ca
2+ at saturating concentration of 2-
oxoglutarate [9,23-25]. Moreover, the apparent Km for
2-oxoglutarate is lowered by a decrease in the ATP/
ADP ratio, which can significantly increase the sensitiv-
ity of the enzyme to Ca
2+ions [23,25]. It has been
reported that the maximum activity of OGDHC is unaf-
fected by changes in pH, while the apparent Km of the
enzyme for 2-oxoglutarate is greatly altered by changes
in pH over the range of 6.5 - 7.5 [23]. A number of stu-
dies have also demonstrated the possible role of Mg
2+
ions in the regulation of OGDHC either by directly
affecting the activity of the enzyme or by modulating
the Ca
2+ effect on the enzyme. Mg
2+ ion has been
shown to increase [26-28] or to have no effect on the
activity of OGDHC [29,30]. McCormack and Denton
[23] studied isolated OGDHC from pig heart mitochon-
dria and found that there is no effect of EDTA and 1
mM Mg
2+ on the activity of OGDHC when Ca
2+ con-
centration was effectively less that 1 μM. Panov and
Scarpa [9] concluded that the effects of Mg
2+ and Ca
2+
ions on the OGDHC activity are additive only at relative
low concentration of free cations which suggested that
at high concentrations, each ion may compete each
other for binding sites. It is also evident that, in the pre-
sence of low Ca
2+ concentration, Mg
2+ ion can strongly
modify the enzyme’s affinities for 2-oxoglutarate and
NAD
-[9]. However, the kinetic mechanisms by which
these divalent metal ions regulate the properties of
mitochon-drial OGDHC are not understood.
Although a number of attempts have been made to
understand the catalytic mechanisms of OGDHC, both
experimentally and theoretically, there is no mechanistic
model that consistently explains the available experi-
mental data on the kinetics of this enzyme complex and
adequately describes the regulatory roles of nucleotides
and other metal ion cofactors (Ca
2+,M g
2+,e t c . ) .T h e r e -
fore a mechanistic model of OGDHC is needed to
understand the orchestrated controlling of OGDHC by
cofactors inside mitochondria under different physiolo-
gical conditions. In the present work, a kinetic model of
OGDHC is introduced to quantitatively understand the
catalytic properties and regulation of OGDHC, based on
the observations from a large number of independent
experimental studies in mammalian tissues. The model
accurately describes the catalytic properties of this
enzyme complex observed experimentally, and clarifies
many contradictory results reported in earlier studies.
Methods
In this section, we first present a general kinetic model
for conformational changes in OGDHC, based on a pre-
sumed ter-ter enzyme mechanism via substrate channel-
ing. The model is then used to characterize the kinetics
of the 2-oxoglutarate dehydrogenase reaction (Equation
1) and further extended to describe the regulatory roles
of cofactors, i.e., nucleotides and various metal ions.
The kinetic parameters of the model are estimated using
a wide variety of experimental data, available in the
literature.
Kinetic scheme for conformational changes in a ter-ter
enzyme mechanism
The kinetic equation of the proposed model for
OGDHC reaction is derived from a ter-ter enzyme me-
chanism combined with a model of conformational
changes that represent the rotation of the single lipoic
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tion is inspired by a previously developed model for
trans-carboxylase [31]. The assumption of the model is
that the enzyme complex is composed of three sub-
enzyme (E1, E2, and E3), each with one binding site:
site 1 binds to 2-oxoglutarate (aKG
2-) or corresponding
product CO2, site 2 binds to CoASH
4- or corresponding
product Succinyl-CoA
4-,s i t e3b i n d st o N A D
- or corre-
sponding product NADH
2- (Figure 1A). Furthermore,
the basic mechanism involves conformational changes,
where the rotation of one lipoic acid between three cat-
alytic sites leads to transfer of succinyl from E1 to E2
and proton from E2 to E3. In the catalytic cycle, the dis-
ulfide at the tip of the lipoyl can be in oxidized, reduced
or semi-reduced li-poate forms, the semi-reduced form
is bound with succinyl residue transferred from 2-oxo-
glutarate (Figure 1B).
Each of the six conformational states shown in Figure
1B can involve any possible binding states associated
with the enzyme. For example, the first site is either
empty or bound to 2-oxoglutarate or CO2;t h es e c o n d
site is either empty or bound to CoASH
4- or Succinyl-
CoA
4-; and the third site is either empty or bound to
NAD
- or NADH
2-. Therefore, there are a total of 27
binding states for each one of the six conformational
states, which gives rise to 27 × 6 = 162 distinct states in
the model. Here we denote these 162 states as Ei
xyz,
where i Î { 1 ,2 ,3 ,4 ,5 ,6 }r e p r e s e n t st h ei n d e xf o rc o n -
formational states, and x Î {Ø, A, P}, y Î {Ø, B, Q} and
z Î {Ø, C, R} represent the binding states of site 1, site
2, and site 3. The lower-case ei
xyz is used to represent
the fraction of each state. Therefore, the total fractional
states can be expressed as
ei
total =
 
x∈{∅,A,P},y∈{∅,B,Q},z∈{∅,C,R}
ei
xyz. (2)
We assume rapid equilibrium binding for all 27 bind-
ing states, implying that the binding processes are much
faster than the conformational change processes. With
this assumption, Equation (2) can be written as:
ei
total = ei
free ×
 
1+[ A ] / KA +[ P ] / KP
 
×
 
1+[ B ] / KB +[ Q ] / KQ
 
×
 
1+[ C ] / KC +[ R ] / KR
 
,
(3)
where ei
free ≡ ei
∅∅∅ denotes the fraction of free enzyme
complex that binds to the reactants; KA,K B,K C,K P,K Q
and KR are the dissociation constants associated with
the binding of reactants (A: aKG
2-,B :C o A S H
4- and C:
NAD
-) and products (P: CO2, Q: Succinyl-CoA
4- and R:
NADH
2-) to the enzyme complex. Here, we assumed
that these constants do not depend on conformational
states of the enzyme complex and the bound reactant at
one site does not influence the binding reaction at
another site: all binding interactions are independent of
one other. These assumptions are necessary to make the
model tractable, and are validated by comparing the
model predictions to the available experimental data.
We define fi as the fractions in conformation state i (i
Î {1, 3, 5}) which can undergo forward conformational
transformation to state i+1 (lipoate changes in three dif-
ferent redox forms). Similarly, f-i is the fraction in con-
formation state i+1 which can undergo conformational
transformation in the reverse direction (Figure 1B). Spe-
cifically, the binding of 2-oxoglutarate at site 1 is neces-
sary for transition from conformation state 1 to 2.
Therefore, we can write
f1 =
 
[A]/KA
1+[ A ] / KA +[ P ] / KP
 
,
f -1=
 
[P]/KP
1+[ A ] / KA +[ P ] / KP
 
,
f3 =
 
[B]/KB
1+[ B ] / KB +[ Q ] / KQ
 
,
f -3=
 
[Q]/KQ
1+[ B ] / KB +[ Q ] / KQ
 
,
f5 =
 
[C]/KC
1+[ C ] / KC +[ R ] / KR
 
,
f -5=
 
[R]/KR
1+[ C ] / KC +[ R ] / KR
 
.
(4)
The net turn-over (reaction velocity) for this mechan-
ism can be expressed
v =
V
[Etotal]
= f5k5[e5
total] − f−5k−5[e6
total]. (5)
Applying the King and Altman method to the scheme
shown in Figure 1B gives the following expression for
the net reaction velocity:
v =
f1f3f5k1k2k3k4k5k6 − f−1f−3f−5k−1k−2k−3k−4k−5k−6
⎛
⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜
⎜
⎝
f−1f−3k−1k−2k−3k−4(k6 + k−6)+f−1f5k−1k−2k4k5(k6 + k−6)
+f3f5k2k3k4k5(k6 + k−6)+f−3f−5(k2 + k−2)k−3k−4k−5k−6
+f−3f1(k2 + k−2)k−3k−4k1k6 + f1f5(k2 + k−2)k1k4k5k6
+f1f3(k4 + k−4)k1k2k3k6 + f−1f−5(k4 + k−4)k−5k−6k−1k−2
+f3f−5(k4 + k−4)k−5k−6k2k3 + f−1f−3f5k−1k−3k5k−2(k6 + k−6)
+f−1f3f5k−1k3k5k4(k6 + k−6)+f−3f−5f1k−3k−5k1k−4(k2 + k−2)
+f−3f1f5k−3k1k5k6(k2 + k−2)+f−1f−5f3k−1k−5k3k−6(k−4 + k4)
+f−5f1f3k−5k1k3k2(k4 + k−4)+f1f3f5k1k3k5(k4k2 + k6k4 + k2k6)
+f−1f−3f−5k−1k−3k−5(k−2k−4 + k−4k−6 + k−6k−2)
⎞
⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟
⎟
⎠
.
(6)
This complex expression can also be obtained using
our KAPattern package [32], available freely for the deri-
vation of enzyme rate equations. Substituting the frac-
tional occupancy distributions as defined in Equation
(4), we obtain an expression for the reaction velocity in
terms of the individual rate constants and dissociation
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in terms of various rate constants. Using the Haldane
relationship, the velocity equation can be written as:
v =
VfVr
 
[A][B][C] − [P][Q][R]/Keq
 
⎛
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜ ⎜
⎜
⎜ ⎜
⎜ ⎜
⎜
⎝
Vr[A][B][C] + KmCVr[A][B][R]/Kir
+KmCVr[A][B] + KmBVr[A][C][Q]/Kiq
+KmBVr[A][C] + KmPVf[A][Q][R]/Kia/Keq
+KicKmBVr[A][Q]/Kiq + KmAVr[B][C][P]/Kip
+KmAVr[B][C] + KiaKmCVr[B][P][R]/Kip/Kir
+KiaKmCVr[B][R]/Kir + KibKmAVr[C][P][Q]/Kiq/Kip
+KibKmAVr[C][P]/Kip + Vf[P][Q][R]/Keq
+KmRVf[P][Q]/Keq + KmQVf[P][R]/Keq + KmPVf[Q][R]/Keq
⎞
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟ ⎟
⎟
⎟ ⎟
⎟ ⎟
⎟
⎠
,
(7)
where the kinetic constants are defined as:
Vf = num1/CoefABC, Vr = num2/CoefPQR, KmA = CoefBC/CoefABC, KmB = CoefAC/CoefABC,
KmC = CoefAB/CoefABC, KmP = CoefQR/CoefPQR, KmQ = CoefPR/CoefPQR, KmR = CoefPQ/CoefPQR,
Kip = CoefBR/CoefBPR = CoefBC/CoefBCP, Kiq = CoefCP/CoefCPQ = CoefAC/CoefACQ,
Kir = CoefAQ/CoefAQR = CoefAB/CoefABR, Kia = CoefQR/CoefAQR = CoefBR/CoefABR,
Kib = CoefPR/CoefBPR = CoefCP/CoefBCP, Kic = CoefPQ/CoefCPQ = CoefAQ/CoefACQ and
Keq = num1/num2.
Here we used the shorthand notation similar to that of
Segel [33] where num = k1 k2 k3 k4 k5 k6KPKQKR,n u m= k-1
k-2 k-3 k-4 k-5 k-6KAKBKC,a n dCoefAB =K CKPKQKR (k1 k2 k3
k6 (k4 + k-4)), and so on. Vf and Vr have units of mass per
unit time per mass of protein. Other kinetic parameters
associated with the binding of reactants and products have
the units of concentration (mass per unit volume).
In the ter-ter biochemical reaction, the fourteen
unknown kinetic parameters in Equation (7) are related
to the equilibrium constant Keq (known) via the follow-
ing equilibrium relationship:
Keq =
 
[P][Q][R]
[A][B][C]
 
eq
=
num1
num2
=
KipKiqKir
KiaKibKic
=
VfKmPKiqKir
VrKiaKmBKic
=
VfKipKmQKir
VrKiaKibKmC
=
VfKipKiqKmR
VrKmAKibKic
,
(8)
reducing the total number of independent unknown
kinetic parameter to thirteen.
Kinetic model of OGDHC using a ter-ter enzyme
mechanism
We apply the above general form of the ter-ter enzyme
mechanism for the analysis of available expe-rimental
data on the kinetic of OGDHC to estimate the unknown
kinetic parameters and to elucidate whether the proposed
mechanism is able to explain the available kinetic data.
In the TCA cycle, OGDHC is primarily involved in
the fifth step for oxidation of acetyl-CoA. The reference
chemical reaction is given by Equation (1). The corre-
sponding biochemical reaction is given by
αKG + CoASH
+N A D succinyl − CoA + CO2,tot +N A D H .
(9)
Here biochemical reactants, such as aKG, correspond
to ensemble chemical species, such as aKG
2-,HaKG
-,
etc. The chemical reaction in Equation (1) is unambigu-
ously balanced in terms of mass and charge, whereas
this biochemical reaction is not. In this reaction, the
reactant CO2, tot represents the sum of aqueous carbon
dioxide and bicarbonate species (CO2−
3 , HCO−
3 and
H2CO3).
The equilibrium constant for the reference reaction
can be written as:
K0
eq,ogdhc =
 
[Succinyl - CoA4−][CO
2−
3 ][NADH2−][H + ]
[αKG2-][CoASH4−][NAD−]
 
eq
= exp
 
−
 rG0
ogdhc
RT
 
,
(10)
where  rG0
ogdhc is the standard Gibbs free energy of
the reference reaction which is computed using the
basic thermodynamic data (298.15 K, I = 0.15 M) listed
in Li et al. [34].
For the development of the kinetic model of OGDHC,
we assume that the ter-ter enzyme mechanism proposed
in the previous section along with the conformational
changes (Figure 1B) can explain the observed kinetics of
OGDHC. Because the kinetic data we used here to esti-
mate the unknown kinetic parameters were all from the
initial velocity studies in which only the products
NADH
2- and Succinyl-CoA
- were present in the reac-
tion mediums, the forward flux of OGDHC can be
reduced from Equation (7) as:
J+
ogdhc =
Vf[A][B][C]
⎛
⎜
⎜ ⎜
⎜
⎜ ⎜
⎝
[A][B][C] + KmC[A][B][R]/Kir
+KmC[A][B] + KmB[A][C][Q]/Kiq
+KmB[A][C] + KicKmB[A][Q]/Kiq
+KmBKic[A][Q][R]/Kiq/Kir
+KmA[B][C] + KiaKmC[B][R]/Kir
+KmBKicKia[Q][R]/Kiq/Kir
⎞
⎟
⎟ ⎟
⎟
⎟ ⎟
⎠
,
(11)
where [A], [B], [C], [R] and [Q] represent the concen-
trations of aKG
2-, CoASH
4-, NAD
-, NADH
2-, and Succi-
nyl-CoA
4-, respectively. This kinetic expression for
OGDHC reaction contains 8 unknown kinetic para-
meters. Thus, this expression was used first to estimate
the 8 unknown kinetic parameters. Using the relation-
ship J+
ogdhc/J
−
ogdhc = exp( G/RT) to determine the reverse
flux [35], we obtain the full flux expression for OGDHC
as:
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ogdhc − J−
ogdhc
= J+
ogdhc
⎛
⎜ ⎜
⎜
⎜
⎝
1 −
1
K0
eq,ogdhc
 
[Succinyl - CoA4−][CO
2−
3 ]
[NADH2−][H + ]
 
 
[αKG2-][CoASH4−][NAD−]
 
⎞
⎟ ⎟
⎟
⎟
⎠
(12)
The kinetic expressions for the regulatory effects of
various cofactors on OGDHC (which depend on 10
additional kinetic parameters) are parameterized in the
Results section, and are estimated separately (see
below). Because CO2, tot dependent terms are not
included in the denominator in Equation (11), CO2, tot
dependent product inhibition is not accounted for in
Equation (12).
Parameter estimation
The developed kinetic model of OGDHC has 8 adjusta-
ble parameters for catalytic mechanism and 10 adjusta-
ble parameters for cofactor regulation (Table 1).
Parameter values were estimated in a systematic modu-
lar manner in multiple steps by least-squares fitting of
the model simulated steady-state flux to the available
experimental data as detailed in Results section below.
The FMINCON algorithm in MATLAB (The Math-
Works, Natick, MA) was used to solve this non-linear
optimization problem. In addition, sensitivity analysis
was performed to estimate the sensitivity of the least
square error to small changes in the optimal parameter
values. The sensitivity was computed using:
Si =
max
  
 E∗
i (xi ± 0.1xi) − E∗
i (xi)
 
  
0.1E∗
i (xi)
, (13)
where E* is the least square difference between model
simulations and experimental data, and xi is the opti-
mized value of the i
th parameter.
Since all kinetic parameters in the model are mea-
sured relative to species concentration, we performed a
composition analysis to estimate the concentration of all
ionic species all experiments analyzed here [36].
Results
Parameterization of basic kinetic mechanism of OGDHC
In this section, we present the detailed parameterization
and validation of the proposed kinetic model based on
the available experimental data on the kinetics of
OGDHC, measured in a wide variety of experimental
conditions. To study the catalytic mechanism of
OGDHC, McMinn and Ottaway [20] investigated the
kinetic properties of the OGDHC system, which was
prepared from fresh pig heart mitochondria. Following
the method of Fromm [21] in which it was concluded
from initial velocity studies that the catalytic mechanism
of OGDHC is not consistent with the Hexa-Uni-Ping-
Pong mechanism. While their observations suggest a
random order kinetic mechanism with respect to the
binding of NAD
- and CoASH
4- and release of Succinyl-
CoA
4-, the binding of 2-oxoglutarate and release of CO2
is described as a Ping-Pong mechanism. Initial velocity
kinetics measured by Smith et al. [10] with purified pig
heart mitochondria OGDHC showed that Succinyl-
CoA
4- and NADH
2- were inhibitors, but no inhibitory
effects were observed with GTP or ATP. Their results
also show that Succinyl-CoA
4- inhibition was competi-
tive with CoASH
4- and independent of the NAD
- oxida-
tion-reduction state. These data are used here to
identify the kinetic parameters of our OGDHC model.
The experimental data in Figure 2 were used to esti-
mate the values of unknown kinetic parameters that
govern the basic catalytic mechanism of OGDHC
(Equation (12)) based on the best fits of the model to
the data (See Figure caption for details). Measured
enzyme activity is expressed in μmoles NADH
2-
formed/mg protein/min. We follow a systematic opti-
mization procedure to estimate each kinetic para-
meter of the model using appropriate experimental
Table 1 Kinetic parameter values for 2-oxoglutarate dehydrogenase complex
Basic kinetic parameters Kinetic parameters for regulatory cofactors
Parameter: Value Sensitivity Parameter: Value Sensitivity
Vmax μmol mg
-1 min
-1a -- KaCa (μM) 0.893 0.293
KmA (mM) 0.273 3.601 KiATP (mM) 0.106 0.943
KmB (μM) 6.96 0.934 KiADP (mM) 0.305 2.073
KmC (μM) 98.6 2.839 KaMg (μM) 19.49 0.228
Kia (mM) 75.9 1.981 α0
Ca 0.262 9.648
Kir (mM) 2.4 1.995 aATP 6.694 1.628
Kic (mM) 0.112 3.970 aADP 0.173 4.412
Kiq (μM) 0.218 5.224 aMg 1.00 6.594
KaH (pH) 6.11 3.623 bMg 4.222 4.603
a We cannot estimate the value of parameter Vf, max in the model without knowing the enzyme activity in the experimental setup. The value of Vmax reported in
the table is equal X × Vf, max, where X is the enzyme activity. The optimization estimates that Vmax ≈ 2.16 μmol mg
-1 min
-1 for Figure 2, Vmax ≈ 11.033 unit/mg for
Figure 3 and Figure 4, Vmax ≈ 167 nmol mg
-1 min
-1 for Figure 5.
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Page 6 of 15data. In the first step, Figure one of McMinn and Ott-
away [20] is used to determine the parameters KmA,
KmB and KmC. Because these data describe the
changes in the initial rate of OGDHC activities in
response to variations in the concentration of differ-
ent substrates in the absence of products, they facili-
tate identifying the kinetic parameter associated with
the binding of 2-oxoglutarate, CoASH
4-,a n dN A D
- .
Next, the kinetic data from Figure three of McMinn
and Ottaway [20] are used to estimate Kia and Kir.
Finally, the kinetic results from Figure five of Smith et
al. [10] are used to determine the last two parameters
related to Succinyl-CoA
4- inhibition: Kic and Ki q.
Henceforth, these kinetic parameters are fixed at their
estimated values (Table 1).
Parameterization of the cofactor-dependent regulatory
mechanisms
Denton et al. [23] conducted a number of experiments
to study the effects of Ca
2+, pH, and adenine nucleo-
tides on the activity of OGDHC from pig heart mito-
chondria. Their data are used here to identify the
kinetic parameters that characterize the activation/
inhibition mechanism of Ca
2+,p H ,a n da d e n i n e
nucleotides (See Figure caption for details). Enzyme
activities are expressed as units of enzyme activity per
F
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Figure 2 OGDHC activity as a function of different substrate and product concentrations. (A) OGDHC activity as a function of 2-
oxoglutarate concentration at different NAD and CoASH concentrations in the absence of products. Kinetic data were obtained from Figure One
A of [20]. Concentration of substrates NAD and CoASH in the assay were fixed to: 0.033 mM and 0.005 mM (square); 0.066 mM and 0.01 mM
(down-triangle); 0.133 mM and 0.02 mM (up-triangle); 0.333 mM and 0.05 mM (circle). (B) OGDHC activity as a function of CoASH concentration
at different 2-oxoglutarate and NAD concentrations in the absence of products. Kinetic data were obtained from Figure One B of [20].
Concentration of the substrates 2-oxoglutarate and NAD in the assay were fixed to: 0.025 mM and 0.02 mM (square); 0.05 mM and 0.04 mM
(down-triangle); 0.1 mM and 0.08 mM (up-triangle); and 0.5 mM and 0.4 mM (circle). (C) OGDHC activity as a function of NAD at different 2-
oxoglutarate and CoA concentrations in the absence of products. Kinetic data were obtained from Figure One C of [20]. Concentration of the
substrates 2-oxoglutarate and CoASH in the assay were fixed to: 0.05 mM and 0.005 mM (square); 0.1 mM and 0.01 mM (down-triangle); 0.2 mM
and 0.02 mM (up-triangle); and 0.5 mM and 0.05 mM (circle). (D) OGDHC activity as a function of NAD at different 2-oxoglutarate and CoASH
concentrations in the presence of products NAGH. Kinetic data were obtained from Figure Two B of [20] and rescaled for data consistence.
Concentration of the substrates 2-oxoglutarate and CoASH in the assay were fixed to: 0.5 mM and 0.05 mM. NADH concentration were 0.0
(circle), 0.01 mM (up-triangle), 0.02 mM (down-triangle) and 0.05 mM (square). (E) OGDHC activity as a function of CoASH concentration in the
presence of product Succinyl-CoA. Kinetic data were obtained from Figure Five A of [10]. Concentration of the substrates 2-oxoglutarate and
NAD in the assay were fixed to: 1.0 mM and 336 μM. Succinyl-CoA concentration were 0.0 (circle), 6.6 μM (up-triangle), and 13.2 μM (down-
triangle). (F) OGDHC activity as a function of CoASH concentration in the presence of products Succinyl-CoA and NADH. Kinetic data were
obtained from Figure Five B of [10]. Concentration of the substrates 2-oxoglutarate and NAD in the assay were fixed to: 1.0 mM and 16 μM.
NADH concentration was 42 μM. Succinyl-CoA concentration were 0.0 (circle), 6.6 μM (up-triangle), and 13.2 μM (down-triangle). Solid lines are
model fitting results from the data points represented by symbols. Experimental data were obtained in 0.08 mM potassium phosphate buffer at
pH 7.2 and 30°C in Figures 2A-2D, and in 0.1 mM potassium phosphate at pH 7.2 and 22°C in Figures 2E-2F.
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Page 7 of 15mg of protein. (One unit of activity is the amount of
enzyme which transforms 1 μmol of substrate per min-
ute at 30°C).
To fit the data that describe the regulatory effects of
Ca
2+ from Figures 3 and 4 of Denton et al. [23], it is
necessary to account for mechanisms of allosteric
activation/inhibition of Ca
2+ in the model. It has been
shown that Ca
2+ can significantly affect the function
of OGDHC by modulating the enzyme affinity for 2-
oxoglutarate, showing a sigmoidal kinetics. Here we
propose a general scheme of nonessential and mixed-
type activation to characterize the effects of Ca
2+.
Based on this scheme, we assume the presence of two
binding sites for Ca
2+ on OGDHC and modify Vmax
and Km of the enzyme complex for 2-oxoglutarate as
follows:
Vmax,1 = Vmax,0
⎛
⎜
⎜ ⎜
⎝
1+
βCa[Ca2+]
αCaKaCa
+
βCa[Ca2+]
2
(αCaKaCa)2
1+
[Ca2+]
αCaKaCa
+
[Ca2+]
2
(αCaKaCa)2
⎞
⎟
⎟ ⎟
⎠
,
KmA,1 = KmA,0
⎛
⎜ ⎜
⎜
⎝
1+
[Ca2+]
KaCa
+
[Ca2+]
2
K2
aCa
1+
[Ca2+]
αCaKaCa
+
[Ca2+]
2
(αCaKaCa)2
⎞
⎟ ⎟
⎟
⎠
.
(14)
The modified flux expression for OGDHC is obtained
by substituting Equation (14) into Equation (11). Three
adjustable parameters (aCa, bCa, and KaCa) are estimated
based on the data from Denton et al.[ 2 3 ] ;t h em o d e l
fits are shown in Figure 3A-B. For model simulations,
the kinetic constants for substrates: 2-oxoglutarate,
NAD
-,a n dC o A S H
4- are fixed at their previously
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Figure 3 OGDHC activity regulated by calcium and pH. (A) OGDHC activity as a function 2-oxoglutarate concentration with 1.0 mM NAD,
0.25 mM CoASH, and in the presence of 5 mM EGTA (circle) or 5 mM EGTA plus 5 mM CaCl2 (up-triangle)Kinetic data were obtained from
Figure Three of [23]. (B) OGDHC activity as a function free calcium concentration in the presence of 1.0 mM NAD, 0.25 mM CoA and 0.1 mM 2-
oxoglurate. Kinetic data were obtained from Figure Four of [23]. (C) OGCHC activity as a function of pH in the presence of 1.0 mM NAD, 0.25
mM CoASH with additions of 0.1 mM 2-oxoglurate plus 5 mM EGTA plus 5 mM CaCl2 (up-triangle) or plus 5 mM EGTA (circle), or with additions
of 25 mM 2-oxoglutarate plus 5 mM EGTA plus 5 mM CaCl2 (square) or plus 5 mM EGTA (down-triangle). Kinetic data were from Table 2 in [23].
Solid lines are model fitting results for the data points represented by symbols. Measurements were conducted at pH 7.0 and 30°C for Figure 3A
and pH 6.8 and 30°C for Figure 3B and all in 50 mM MOPS buffer plus 1 mM dithiothreitol and with additions of appropriate substrates.
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Figure 4 OGDHC activity regulated by nucleotide with and without calcium (A, B) OGDHC activity as a function of various concentrations
of ATP (circle), ADP (up-triangle) or ADP with 1.5 mM ATP (down-triangle) in the presence of 1.0 mM NAD, 0.25 mM CoASH, with the addition
of either 0.1 mM 2-oxoglurate plus 5 mM EGTA plus 5 mM CaCl2 (A) or 2 mM 2-oxoglurate plus 5 mM EGTA (B). Kinetic data were obtained
from Figure Five of [23]. (C) OGDHC activity as a function of ADP/ATP ratio in the presence of 1.0 mM NAD, 0.25 mM CoASH and either 0.1 mM
2-oxoglurate plus 5 mM EGTA plus 5 mM CaCl2 (circle) or 2 mM 2-oxoglurate plus 5 mM EGTA (up-triangle). Kinetic data were obtained from
Figure Six of [23]. Solid lines are model fitting results for the data points represented by symbols.
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Page 8 of 15estimated values, obtained from data of McMinn and
Ottaway [20]. Based on the fits to these data we find
that bCa is close to one. For simplicity, we fixed bCa =1 ,
meaning that Ca
2+ affects only the Km of 2-oxoglurate,
not the Vmax. This mechanism is also consistent with
the conclusions of Denton et al. [23]. (Statistical analysis
of different model formulizations supports the validity
of the null hypothesis that adding the extra adjustable
parameters, bCa, does not lead to any significant
improvement in fitting results.) The estimated values of
the kinetic parameters are summarized in Table 1.
Experimentally it has been shown that the maximal
activity of OGDHC is largely unaffected by changes in pH
over the range 6.6-7.4, whereas the Km o ft h ee n z y m ei s
markedly altered by pH in this range [23]. In our model,
the effect of pH on the OGDHC activity was described
based on the observations studies of Denton and collea-
gues [23]. Here, protons are treated as the essential activa-
tors of OGDHC which increase the binding affinity of the
enzyme to 2-oxoglutarate. Therefore, the Km of 2-oxoglu-
rate is modified by multiplying the term KaH/[H
+]s u c h
that KmA,1=( KmA,1 KaH)/[H
+] (in Equation (15)). Figure
3C illustrates the model fits to the data obtained from
Table 2 in McCormack and Denton [23] where the activity
of ODGHC was studied under varying pH in both pre-
sence and absence of Ca
2+ in the buffer.
Denton and colleagues [23] also studied the effect of
adenine nucleotides (ATP and ADP) on the OGDHC
activity where it was shown that both ATP and ADP
significantly impact the Km of the en-zyme for 2-oxoglu-
tarate and that the regulations of OGDHC by Ca
2+ and
adenine nucleotides seem to be independent. Here the
regulatory effects of nucleotides on OGDHC activity is
modeled as similar to that of Ca
2+. Specifically, we
assume that there are different binding sites on the
OGDHC that bind to ATP or ADP. (The available
kinetic data cannot exclude the other possibility that
ATP and ADP can bind at the same site.) Therefore, the
Vmax and Km for 2-oxoglutarate was modified as a func-
tion of nucleotide concentrations as follows:
Vmax,2 = Vmax,1
 
1+
βATP[ATP]T
αATPKATP
  
1+
βADP[ADP]T
αADPKaADP
 
 
1+
[ATP]T
αATPKATP
  
1+
[ADP]T
αADPKaADP
  ,
KmA,2 = KmA,1
 
1+
[ATP]T
KiATP
  
1+
[ADP]T
KaADP
 
 
1+
[ATP]T
αATPKiATP
  
1+
[ADP]T
αADPKADP
 
KaH
[H + ]
.
(15)
where [ATP]T and [ADP]T represent the total concen-
trations of the nucleotides. Experimental results show
that neither free nucleotides nor magnesium binding
nucleotides are solely responsible for activation
observed. More data are needed to quantitatively and
qualitatively specify the activation effects of each nucleo-
tide’s ionic forms. Figure 4(A-C) are model fits to the
data obtained from Figures 5 and 6 of Denton and col-
leagues [23]. Optimization results based on these data
indicate that both ATP and ADP change the Km of
OGDHC for 2-oxoglutarate without altering the maxi-
mum activity, which suggests that both bATP and bADP
are equal to one.
Mg
2+ is known to regulate the activity of OGDHC. In
a recent study, Rodriguez-Zavala et al.[ 3 7 ]e x a m i n e d
the effects of ligands, such as ATP, ADP, Ca
2+, and Mg
2
+ on the activity of OGDHC in both isolated pig heart
enzyme complex and mitochondrial extracts. These data
facilitate the characterization of the regulatory effect of
Mg
2+ on the OGDHC activity and are used here to esti-
mate the Mg
2+ associated kinetic parameters. Enzyme
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Figure 5 OGDHC activity regulated by magnesium (A) OGDHC activity of isolated enzyme as a function of ADP in the presence of 1.0 mM
NAD, 0.25 mM CoASH, and 0.5 mM 2-oxoglurate with additions of 0.0 (circle), 25 μM (up-triangle), 50 μM (down-triangle) and 200 μM (square)
Mg
2+. Kinetic data were obtained from Figure Two of [37]. (B-C) OGDHC activity as a function of 2-oxoglutarate in the presence of 1.0 mM NAD,
0.25 mM CoASH with 600 μM (B) or 0 μM (C) Mg
2+ addition. (up-triangle) no further additions (control); (circle) +600 μM ATP; (down-triangle)
+600 μM ADP. Kinetic data were obtained from Figure Four of [37]. Vmax has been changed less than 10% to better fit the symbols. Solid lines
are model fitting results for the data points represented by sym-bols. The experimental data were obtained at pH 7.35 and 30°C in 120 mM KCl,
20 mM MOPS-K, 0.5 mM EGTA buffer.
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Page 9 of 15activity is measured in nmol NADH
2+ formed per min-
ute per mg protein.
Experimental data from purified OGDHC from pig
heart mitochondria from Rodriguez-Zavala et al. [37]
with zero Mg
2+ were used to estimate the Vmax of the
enzyme. Figure 5B shows the model simulations (lines)
using the parameter estimates obtained above, with the
exception that Vmax was adjusted to match these experi-
mental data. Data in Figure 5A with non-zero Mg
2+ con-
centration and the data in Figure 5C are then used to
estimate the kinetic parameters associated with the bind-
ing of Mg
2+. Our model fits to these data assume that
Mg
2+ not only increases the activity by binding to the
enzyme complex, but also potentiates the 2-oxoglutarate
affinity to the enzyme and decrease the Km of OGDHC
for 2-oxoglutarate. Specifically, we assume two binding
sites for Mg
2+ and modify the Vmax and the Km as
Vmax,3 = Vmax,2
⎛
⎜ ⎜
⎜ ⎜
⎝
1+
βMg[Mg2+]
αMgKaMg
+
βMg[Mg2+]
2
 
αMgKaMg
 2
1+
[Mg2+]
αMgKaMg
+
[Mg2+]
2
 
αMgKaMg
 2
⎞
⎟ ⎟
⎟ ⎟
⎠
,
KmA,3 = KmA,2
⎛
⎜
⎜
⎜ ⎜
⎝
1+
[Mg2+]
KaMg
+
[Mg2+]
2
K2
aMg
1+
[Mg2+]
αMgKaMg
+
[Mg2+]
2
 
αMgKaMg
 2
⎞
⎟
⎟
⎟ ⎟
⎠
(16)
T h ed a t as h o w ni nF i g u r e5a re used to estimate the
adjustable kinetic parameters related to Mg
2+ ions in
our kinetic model for OGDHC. Fits to the data are
plotted in Figure 5 and the parameter values
summarized in Table 1. The developed model is able to
satisfactorily explain the effect of Mg
2+ ions on the
enzyme activity. These results, combined with those
shown in Figures 2 and 3, imply that the matrix free
Ca
2+ and Mg
2+ ions concentrations exert significant and
distinct effects on the OGDHC activity.
Complete flux expression for the 2-oxoglutarate
dehydrogenase complex
Based on the proposed mechanisms of allosteric activa-
tion and inhibition of various cofactors, the flux expres-
sion (Equation (11)) of the OGDHC can be further
modified. Applying the catalytic and regulatory mechan-
isms of Equations 14-16, the final forward flux expres-
sion is
J+
ogdhc =
Vf[A][B][C] · N
⎛
⎜ ⎜
⎜ ⎜
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⎟ ⎟
⎠
(17)
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Figure 6 Predictions of OGDHC activity comparing with experimental results. (A) OGDHC activity as a function of free calcium
concentration in present of 2.0 mM NAD and 0.25 mM CoASH in the presence of either 1.5 mM ATP (circle) or 1.5 mM ADP (up-triangle).
Concentrations of 2-oxoglutarate were 0.05 mM (ADP alone) and 0.1 mM (ATP alone). Kinetic data were obtained from Figure Three of [38]. (B)
OGDHC activity as a function of ADP/ATP ratio in the presence of 2.0 mM NAD, 0.25 mM CoASH and 0.05 mM 2-oxoglutarate in the presence of
either 1.0 nM (circle) or 1.0 μM (up-triangle) free Ca
2+. Kinetic data were from Figure Four of [38]. (C) OGDHC activity as a function of NADH/
NAD ratio 0.35 mM Mg
2+ and 0.4 mM total nicotinamide nucleotide in the assay. Ca
2+ concentration was either 1 nM (circle) or 0.1 mM (up-
triangle) and 2-oxoglutarate concentration was 10 mM (circle) or 0.375 mM (up-triangle). Kinetic data were obtained from Figure Five b of [38].
Solid lines are model predictions for the data points represented by symbols. The experimental data were obtained at pH 7.2 and 30°C in
reaction medium of 50 mM MOPS, 75 mM KCl, 60 mM sucrose, 2 mM KH2PO4, 1 mM EGTA.
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  .
Estimated values of KaH,K iATP,K aADP,K aMg, aADP,
aATP, aCa, aMg, and bMg are listed in Table 1.
Independent validation of the developed kinetic model of
OGDHC
Finally, the model is independently validated (corrobo-
rated) by comparing the model predictions to the initial
rate data of Rutter and Denton [38] on the kinetics of
OGDHC obtained from permeabilized mitochondria and
mitochondrial extracts (see Figure 6(A-C)). They studied
the regulations of NAD-linked isocitrate dehydrogenase
and 2-oxoglutarate dehydrogenase by Ca
2+, nucleotide
and nicotinamide nucleotides in permeabilized rat heart
mitochondria and in mitochondria extracts. Data from
their study were not used for estimation of model para-
meters and used here to further validate the proposed
mechanisms and regulation of OGDHC. Therefore, the
flux expression of Equation (17) was used for simula-
tions with the values of the kinetic parameters the same
as estimated before (see Table 1). The model accurately
describes the kinetics and regulation of OGDHC,
observed experimentally, without having to re-estimate
the model kinetic parameters, signifying the accuracy of
the model and the associated model parameters.
To determine the degree to which the model simula-
tions are sensitive to the estimated parameter values,
the relative sensitivities are computed and listed in
Table 1. A high sensitivity value indicates that a small
change in a given parameter can lead to significant
changes in model outputs, used to identify the para-
meter values. All of our adjustable parameters of the
model have sensitivities over 30%. Two parameter esti-
mates (KaCa and KaMg) show relatively low sensitivity
compared to the others, indicating that predictions of
the developed model are less sensitive to these two
values. This implies that these two parameters may not
be identified accurately by the present analysis, given
the sparseness of the data sets analyzed in this work
regarding the regulation of OGDHC by Ca
2+ and Mg
2+.
Further experiments are required to adequately establish
the appropriate regulatory mechanisms and the robust-
ness of each model parameters.
Discussion
A number of kinetic models have been previously devel-
oped to explain the basic catalytic mechanisms and reg-
ulations by cofactors of OGDHC. Sanadi et al. [12] first
proposed a Hexa-Uni-Ping-Pong mechanism for the
overall reaction by studying various roles and locations
of the cofactors: thiamine pyrophosphate, lipoic acid,
and FAD
2- within this complex. Hemada et al. [19] con-
ducted kinetic studies and proposed a similar mechan-
i s mt ot h a to fS a n d iet al. and suggested that NADH
2-
is a competitive inhibitor of NAD
-.W h e r e a sS m i t het
al. [10] suggested a noncompetitive inhibition of
NADH
2- with NAD
-, the catalytic mechanism was not
consistent with Sandi et al. Later, McMinn and Ottaway
[20] tested a series of possible alternate mechanisms
using computer optimization techniques and initial velo-
city studies and concluded that the binding of NAD
-
and CoASH
4- and the release of Succinyl-CoA
4- is a
random order, whereas the binding of the substrate 2-
oxoglutarate and release of the product CO2 still follows
a Ping-Pong mechanism. Besides above experimental
studies, a number of integrated models of mitochondrial
bioenergetics have been developed which used different
type of OGDHC models. Cortassa et al. [39] describe
the activity of OGDHC as a function of Ca
2+,M g
2+ and
substrate concentrations using phenomenological terms.
Wu et al.[ 4 0 ]u s e das i m p l ek i n e t i cm o d e lo fO G D H C
from Kohn and Garfinkel [41] in their integrated model
of TCA cycle that does not incorporate the regulatory
effect of metal ion cofactors. In a recent integrated
study of mitochondrial bioenergetics, Bazil et al. [42]
developed a kinetic model of OGDHC based on a Hexa-
Uni-Ping-Pong mechanism with a general description of
the cofactor dependency of OGDHC activity. In sum-
mary, there have been a wide variety of kinetic models
of OGDHC with contrasting kinetic mechanism and
cofactor regulations.
In this paper, we developed a unified mechanistic
model of OGDHC, in which Ca
2+,M g
2+, ADP
3-, and pH
are treated as activators and ATP
4- as inhibitor of the
OGDHC activity. The present model offers more realis-
tic and meaningful explanations on the catalytic proper-
ties and regulation mechanisms of OGDHC than
previous attempts. The analysis also provides a unique
set of kinetic parameters that consistently describe a
wide variety of experimental data sets on OGDHC func-
tion, obtained from diverse sources. Based on the
assumed ter-ter mechanism and associated conforma-
tional changes, we are able to consistently reproduce the
observed kinetics of OGDHC with a minimal number of
model parameters. Thus, the proposed mechanism is
f o u n dt ob em o r ea p p r o p r i a t ecompared to other alter-
nate kinetic models [43].
Effects of nucleotides on the OGDHC activity
Energy-linked regulators, ADP and ATP, as well as inor-
g a n i cp h o s p h a t e ,h a v eb e e ni nvestigated for over two
decades for their profound effects on kinetic properties
of OGDHC. Kinetic studies of mammalian OGDHC,
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causes activation of OGDHC [44-47]. This enzyme com-
plex is sensitive to ADP, where ADP significantly
decreases the Km for 2-oxogluterate without affecting
the maximum rate (Vmax) of the reaction via allosteric
interactions. For example, studies on the OGDHC of rat
heart mitochondria show a seven fold decrease in the
Km value for 2-oxogluterate by ADP and thereby
strongly increases the affinity of OGDHC for the sub-
strate [47]. Other studies of OGDHC from human heart
make similar conclusions on the activating effect of
ADP [48]. It has also been shown that, at subsaturating
concentration of 2-oxoglutarate the relationship between
initial reaction rates of OGDHC and concentration of
ADP is sigmoidal, suggesting a positive cooperativity in
binding of ADP to the enzyme complex [49]. In con-
trast, at a suboptimal 2-oxoglutarate concentration, ATP
was shown to inhibit OGDHC activity in pig heart and
bovine kidney mitochondria [23,45]. In addition direct
inhibition effect, recent investigations have shown the
possible indirect inhibition OGDHC by ATP because of
chelation of divalent ions which activate OGDHC, such
as Ca
2+,M g
2+ [37]. The activating action of ADP and
inhibiting action of ATP are in competitive opposition
(Figure 3E). It is still unclear if these two effectors bind
on the same site on the complex or not. Model analysis
based on the available kinetic data cannot exclude either
possibility. In our mechanistic model, the regulatory
effect of ADP and ATP is incorporated by assuming dif-
ferent binding sites for ADP and ATP in the enzyme
complex and the model satisfactorily describes the acti-
vating effect of ADP and inhibitory effect ATP observed
in many experiments [46].
While Zavala et al. interpret the data of Figure 5A to
indicate that MgADP
- is the effective activator of
OGDHC activity, our model analysis of the available
data sets on Mg
2+, ADP, and ATP dependent kinetics
(Figures 4 and Figure 5B and 5C) reveals that, magne-
sium and ADP have independent parallel effects on the
OGDHC activity, the most parsimonious explanation of
the data. However, al-ternative, more complex, models
cannot be ruled out.
Like ADP, Pi has also been shown to decrease the Km
value for 2-oxogutarate, without affecting the Vmax of
OGDHC reaction [44,50]. In a recent report, the Pi acti-
vation showed biphasic behavior, with pH dependence
[37]. In the physiological concentrations range Pi exerts
monophasic activation of OGDHC [37], which can be
descried by Equation (15) with three extra parameters.
Due to the lack of consistent kinetic data for Pi effects,
we do not integrate a Pi dependent regulation mechan-
ism in our current model. However, this energy linked
effector may be physiologically important. The overall
rate of oxidative phosphorylation is largely determined
by phosphorylation potential [51,52]. In cells when ATP
utilization increases, the production of ADP and Pi
increase. Therefore, activation of OGDHC by ADP and
Pi may represent a compensating effect.
Effect of pH on the OGDHC activity
Mitochondrial matrix proton (H
+ ion) concentration is
known to affect the OGDHC properties. Specifically,
studies on pig heart OGDHC showed that the change in
pH in the range 6.6 to 7.4 can significantly alter Km of
the enzyme for 2-oxogluterate, without affecting its
maximal activity. McCormack and Denton illustrated
the effect of pH on OGDHC activity both in the absence
and presence of Ca
2+ in their assay mediums [46]. Other
experimental observations have shown that hydrogen
ions favor the higher affinity of OGDHC for 2-oxogluta-
rate [45,53]. In our model we hypothesize that hydrogen
ions are essential activators of OGDHC activity to
describe the observed pH dependency of the OGDHC
kinetics.
Effects of Ca
2+,M g
2+, and EGTA on the OGDHC activity
Studies by McCormack and Denton demonstrate the
activating effects of Ca
2+ ions on intra-mitochondrial
dehydrogenases: pyruvate (PDH), NAD-isocitrate (NAD-
ICDH), and 2-oxoglutarate (OGDHC) [24,54,55]. Speci-
fically, the rise in cytosolic Ca
2+ concentration in
response to extrinsic stimuli, such as hormones can
enhance mitochondrial oxidative metabolism via direct
activation of these three Ca
2+ sensitive dehydrogenases.
Such mechanisms may serve as a complementary way to
stimulate ATP-synthesis to meet the increased energy
demand of the cell [24,54,55].
Mg
2+ ion has also been shown to regulate the
OGDHC activity either by directly activating the enzyme
or by modulating the Ca
2+ effects on the enzyme. In
some studies, Mg
2+ s h o w sn oe f f e c t so nO G D H Ca c t i v -
ity [23]. However, in other studies, Mg
2+ is shown to
increase the maximal activity of the enzyme and the affi-
nity of OGDHC for 2-oxogluterate by enhancing the
Ca
2+ stimulatory effects on the enzyme complex
[9,25,37]. These different observations could be
accounted for the different levels of endogenous Ca
2+
and Mg
2+ present in the purified enzyme complex pre-
pared by different methods. Another possible explana-
tion is that the stimulatory effects of Mg
2+ is TPP-
dependent, which is not explicitly considered in our
model. Panov and Scarpa [9] found that Mg
2+ only
exerts its stimulatory effects in the presence of TPP,
though exclusion of TPP from the reaction medium has
no effect on the initial enzyme activity in the absence of
Mg
2+. Also, it has been clearly shown that Mg
2+ may
affect the rate of oxidative phosphorylation in isolated
mitochondria primarily via modulating the OGDHC
Qi et al. BMC Biochemistry 2011, 12:53
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2+ ion on OGDHC
is unknown. In the present model, we hypothesized a
general scheme of nonessential activation of Ca
2+,b y
considering two Ca
2+ and Mg
2+ binding sites on
OGDHC. The Mg
2+ effect is incorporated in our model
by exclusively modifying the enzyme activity and 2-oxo-
glutarate binding step. So the parameters Vmax and KmA
are accordingly expressed as functions of Mg
2+ (Equa-
tion (16)). Currently, our model assumes that the turn-
over rate of E1 is modified to same value for binding
either one ion or two ions. And to make it simple, our
model does not include possible interaction between
Mg
2+ and Ca
2+ at high concentrations either. The effects
are not additive [9] at high concentration, suggesting
that Mg
2+ and Ca
2+ may compete for the binding site.
Additional kinetic data set are necessary to test different
mechanisms and refine our model to more accurately
describe the nature of cation dependent kinetic of
OGDHC.
EGTA, which is used in many studies to control Ca
2+
ion concentration in reaction media, has been shown in
experiments and theoretical analysis to inhibit the
NAD-linked isocitrate dehydrogenases (ICDH) through
the binding complex, MgEGTA [36]. To date, it is still
not clear if there is similar inhibition effect of EGTA or
EDTA on the activity of OGDHC. McCormack and
Denton [23] concluded that the OGDHC sensitivity
toEGTA is very similar to that observed with ICDH
[56], because addition of calcium chelators EGTA or
EDTA is associated with a marked decrease in the activ-
ity of OGDHC at 0.2 mM 2-oxoglutarate. Panov and
Scarpa [9], in ascribing the inhibition effect of EGTA to
the complex formation between Ca
2+ and chelators,
c o n c l u d e dt h a tt h ee f f e c t e do fC a
2+ and chelators is
associated with different endogenous cation levels in dif-
ferent preparations. But this explanation cannot account
for McCormack and Denton’s observation that EGTA
or EDTA causes a 40% decrease of activity of OGDHC
after using Chelex remove much of the endogenous Ca
2
+ in the buffer. It is also noted that the KM for 2-oxoglu-
tarate in the absence of Ca
2+ i s4±1 . 1m Mm e a s u r e d
by Panov and Scarpa [9] for commercially available
enzyme (Sigma, St. Louis, lot 44H80801), which is
almost 15 times the estimated value used in our model
(Table 1) and that found by previous workers [19,27].
Only by using the reported KM of Panov and Scarpa [9],
can we reproduce their data using the same mechanism
(Equation (17)). In the absence of clear experimental
evidence and sufficient data set, our model does not
explicitly account for an inhibition effect of EGTA or
EDTA.
Conclusion
Our mechanistic OGDHC model based on a detailed
catalytic mechanism successfully provides a single con-
sistent theoretical explanation for many previously unre-
solved experimental observations on the kinetics and
regulations of OGDHC. In particular, it suggests the
most plausible physiologically regulations of OGDHC by
NAD(H) oxidation-reduction state, the nucleotide phos-
phorylation potential, pH and various metal ions (Mg
2+
and Ca
2+). As a rise in NADH can reduce the OGDHC
flux and thereby provides feedback regulation through
the electron transport chain, it is important to ask how
NAD oxidation-reduction state and oxidative phosphor-
ylation state exert a coherent regulation of OGDHC in
physiological context. Furthermore, how does the
OGDHC respond to stimuli via the mitochondrial Ca
2+
transport system? Such questions may be addressed by
applying the present model in an integrated framework
[43] along with other dehydrogenases [36], the oxidative
phosphorylation system [57], electron transfer system
[58], and cation transport systems [59-61].
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